191 related articles for article (PubMed ID: 7738604)
1. Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program.
Pang YP; Kozikowski AP
J Comput Aided Mol Des; 1994 Dec; 8(6):683-93. PubMed ID: 7738604
[TBL] [Abstract][Full Text] [Related]
2. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the binding sites of huperzine A in acetylcholinesterase by docking studies.
Pang YP; Kozikowski AP
J Comput Aided Mol Des; 1994 Dec; 8(6):669-81. PubMed ID: 7738603
[TBL] [Abstract][Full Text] [Related]
4. Dynamic mechanism of E2020 binding to acetylcholinesterase: a steered molecular dynamics simulation.
Niu C; Xu Y; Xu Y; Luo X; Duan W; Silman I; Sussman JL; Zhu W; Chen K; Shen J; Jiang H
J Phys Chem B; 2005 Dec; 109(49):23730-8. PubMed ID: 16375354
[TBL] [Abstract][Full Text] [Related]
5. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.
Kryger G; Silman I; Sussman JL
Structure; 1999 Mar; 7(3):297-307. PubMed ID: 10368299
[TBL] [Abstract][Full Text] [Related]
6. The rationale for E2020 as a potent acetylcholinesterase inhibitor.
Kawakami Y; Inoue A; Kawai T; Wakita M; Sugimoto H; Hopfinger AJ
Bioorg Med Chem; 1996 Sep; 4(9):1429-46. PubMed ID: 8894101
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica.
Kryger G; Silman I; Sussman JL
J Physiol Paris; 1998; 92(3-4):191-4. PubMed ID: 9789806
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds.
Sugimoto H; Iimura Y; Yamanishi Y; Yamatsu K
J Med Chem; 1995 Nov; 38(24):4821-9. PubMed ID: 7490731
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and acetylcholinesterase inhibitory activity of huperzine A-E2020 combined compound.
Zeng F; Jiang H; Zhai Y; Zhang H; Chen K; Ji R
Bioorg Med Chem Lett; 1999 Dec; 9(23):3279-84. PubMed ID: 10612585
[TBL] [Abstract][Full Text] [Related]
10. Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020).
Nochi S; Asakawa N; Sato T
Biol Pharm Bull; 1995 Aug; 18(8):1145-7. PubMed ID: 8535413
[TBL] [Abstract][Full Text] [Related]
11. Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil.
van Greunen DG; Cordier W; Nell M; van der Westhuyzen C; Steenkamp V; Panayides JL; Riley DL
Eur J Med Chem; 2017 Feb; 127():671-690. PubMed ID: 27823887
[TBL] [Abstract][Full Text] [Related]
12. The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]meth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyses.
Inoue A; Kawai T; Wakita M; Iimura Y; Sugimoto H; Kawakami Y
J Med Chem; 1996 Oct; 39(22):4460-70. PubMed ID: 8893840
[TBL] [Abstract][Full Text] [Related]
13. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
15. Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors.
Sugimoto H; Yamanishi Y; Iimura Y; Kawakami Y
Curr Med Chem; 2000 Mar; 7(3):303-39. PubMed ID: 10637367
[TBL] [Abstract][Full Text] [Related]
16. Docking analysis of a series of benzylamino acetylcholinesterase inhibitors with a phthalimide, benzoyl, or indanone moiety.
Yamamoto Y; Ishihara Y; Kuntz ID
J Med Chem; 1994 Sep; 37(19):3141-53. PubMed ID: 7932538
[TBL] [Abstract][Full Text] [Related]
17. Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase.
Cardozo MG; Kawai T; Iimura Y; Sugimoto H; Yamanishi Y; Hopfinger AJ
J Med Chem; 1992 Feb; 35(3):590-601. PubMed ID: 1738152
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C
Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase protection and the anti-diisopropylfluorophosphate efficacy of E2020.
Galli A; Mori F; Benini L; Cacciarelli N
Eur J Pharmacol; 1994 Apr; 270(2-3):189-93. PubMed ID: 8039548
[TBL] [Abstract][Full Text] [Related]
20. Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates.
Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Ramírez L; Viayna E; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Bidon-Chanal A; Huertas O; Dafni T; Luque FJ
Chem Biol Interact; 2010 Sep; 187(1-3):411-5. PubMed ID: 20167211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
